General Inception

General Inception is a science and technology investment firm with a thesis focused on company creation and early-stage investing in deep tech, frontier biology, and computational platforms. The generalinception.com website and LinkedIn presence indicate a venture studio and investor model rather than a pure financial fund, with a focus on building new companies alongside scientific founders. For healthcare AI founders, General Inception is a credible match if you are at the formation stage with a strong scientific co-founder and ambition to build a category-defining business in computational biology, AI for drug discovery, foundation models for biological data, or other deep science healthcare applications. Plausible check sizes at the inception and seed stage run 500K to 3M, with the firm taking a meaningful equity stake and active operational role given the studio model. Founders building incremental healthcare workflow SaaS or telehealth services should look elsewhere; this is a science and technology incubator, not a vertical SaaS investor. Founders post-formation with mature businesses should also evaluate whether the studio involvement model suits their stage, given that General Inception operates more like a co-founder than a passive investor. Entry path is direct outreach to the leadership team via LinkedIn, or warm introduction through scientific operators in their network. The firm engages with scientific founders directly and is not running a high-volume inbound process. Bring a clear scientific thesis, your technical and clinical co-founders, and a willingness to engage in active company-building partnership. Diligence will be technically substantive and oriented around the durability of the underlying science. The value-add is significant for the right founder: company-building support, scientific network, and credible early capital from a partner who understands deep technology timelines.